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Two Cases of Long-term Coronary Sinus Pacing by Medtronic
Model 6992 Lead
YUJI NAKAZATO1 AND YASURO NAKATA2
From 1Division of Cardiology, Department of Internal Medicine, Juntendo University School of Medicine, Tokyo
and 2Department of Cardiology, Juntendo Izu-Nagaoka Hospital, Shizuoka, Japan
NAKAZATO and NAKATA: Two Cases of Long-term Coronary Sinus Pacing by Medtronic Model 6992 Lead.
In late '70s, coronary sinus (CS) pacing was clinically performed by using several specifically designed lead systems.
However, there is scant long-term follow-up data covering periods more than 15 years. We report two patients with
sick sinus syndrome in whom CS pacing with Medtronic model 6992 lead system was successfully applied for 17 and
21 years, respectively. (J HK Coll Cardiol 2004;12:3-6)
Left atrial pacing, pacing lead, prognosis, sick sinus syndrome
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Introduction
Coronary sinus (CS) is an optional site for atrial
pacing if an optimal site cannot be found in the right
atrium. Although lead dislodgement and/or threshold
rise were observed in limited cases, the long-term
feasibility of the CS pacing method by standard or
specifically designed lead systems has been reported.1,2
However, no follow-up data over 15 years using
Medtronic model 6992 CS lead has been reported. We
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have experienced two patients with sick sinus
syndrome (SSS) in whom CS pacing by this system
was successfully implanted at late '70 and applied
for 17 and 21 years, respectively.

Case Reports
Case 1
The patient was a 77-year-old male with SSS.
At the age of 55, he was implanted with an AAI mode
pacemaker using a Medtronic model 6992 CS lead
(Figures 1a & 1b). Unipolar pacing was performed
because of better thresholds than bipolar pacing. The
voltage (V) and current (mA) thresholds measured
with a pulse width of 0.6 msec were 2.4 V and 7.9
mA respectively at the time of implantation. P-wave
amplitude was 2.1 mV and pacing impedance was
304 ohms. Although two generator changes were
performed at 8 and 12 years following initial implant,
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these parameters remained stable (Table 1).
Thereafter, CS pacing was successfully performed
for 17 years until lead fracture was found at the
vicinity of puncture site. We abandoned the CS lead

(a)

and implanted a new pacing system from the opposite
site. ECG during CS pacing has not changed and no
progression to atrioventricular block was noted
(Figure 1c).

(b)

(c)

Figure 1. Chest X-ray and ECG in Case 1. (a & b) CS
lead is clearly recognizable in the Postero-anterior
and lateral projections. (c) ECG showed stable atrial
pacing. New pacing system implanted after CS lead
fracture is seen at opposite site.

Table 1. Change of measurements at the time of initial implantation and replacement in Case 1
Initial implant

Voltage* (V)
Current* (mA)

('78)
2.4
7.9

1st
('85)
3.2
9.6

Replacement
2nd
('90)
2.2
5.6

P-wave (mV)
Impedance (Ω)

2.1
304

1.8
315

2.4
379

3rd
('95)
fracture
0.3
740

*Measured at pulse width of 0.6 ms
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Case 2
The patient was a 68-year-old female with SSS.
At the age of 48, she had recurrent syncope due to
sinus arrest and CS pacing with a Medtronic 6992
lead was performed (Figures 2a & 2b). At the time
of initial implantation, the voltage and current
thresholds measured at a pulse width of 0.6 msec were
1.2 V and 2.8 mA respectively, and P-wave amplitude
was 3.7 mV all in the unipolar configuration.
Subsequently, the lead remained functional after one
generator change with the last measured thresholds
of 1.3 V and 2.9 mA at 0.6 ms, a P-wave amplitude
of 2.6 mV and lead impedance of 540Ω. Stable CS
pacing has been maintained for 21 years since the
initial implantation. Voltage threshold during the
follow-up period has ranged from 1.8 V to 2.2 V with
a pulse width of 0.5 msec. The ECG has indicated

(a)

constant AAI pacing and no progression to
atrioventricular block is noted during the follow-up
period (Figure 2b).

Discussion
Recent advances in pacing lead technology
have made stable atrial pacing possible. The prevalent
lead fixation sites are the right atrial free wall by
screw-in leads or the right atrial appendage by
J-shaped leads. CS is another optional site for atrial
pacing and several specially designed CS leads were
used before the development of above two lead
systems.1,2 However, the CS lead has the concern of
lead dislodgement and/or threshold rise and their
clinical application was very limited.1-3

(b)

(c)

Figure 2. Chest X-ray and ECG in Case 2. (a & b) CS
lead is clearly recognizable in the Postero-anterior and
lateral projection. (c) ECG showed stable atrial pacing.
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Moss and Rivers2 reported ten-year experience
in 50 patients with CS pacing by Medtronic model 5818
and 6904 bipolar pacing lead. They had 11 electrode
related malpacing events, or a rate of 10% in the first
pacing month, 1.1% per paced month during the next
six months, and 0.25% per paced month thereafter.
Within 7 months, they observed lead dislodgement and
high thresholds as major problems. Effective atrial
pacing was achieved in 76% of the patients during a
follow-up of more than five years. They concluded that
long term atrial pacing from the CS was safe and
effective.
Greenberg et al1 reported 66 patients with CS
pacing by specifically designed leads. During an average
follow-up of 14 months the failure rate was 14% and
they reported 4 cases of lead dislodgement and 4 cases
of threshold rise.
In the present cases, we had a chance to use
Medtronic 6992 leads for CS pacing. Until then, we
had no means of atrial pacing for sic sinus syndrome.
This lead has a straight tapered tip with bipolar
electrodes for obtaining stable fixation. However,
unipolar use with distal electrode provides superior
thresholds as compared to bipolar use. This could be
explained by the fact that proximal electrode more
mobile and could not maintain good contact with
surrounded CS tissues. Ideally, it had been better to fix
the lead in optimal position for good thresholds.
However, if this CS lead was once fixed, it could not be
changed the position for preventing dislodgement. If
the thresholds were not acceptable at this position, we
might have abondoned it and obliged to chose
ventricular pacing. In our 2nd case, voltage and current
thresholds were 1.3 V and 2.9 mA respectively. These
were similar to Greenberg et al's1 and Moss and Rivers's2

6

reports which stated an overall average threshold by
unipolar and bipolar CS pacing as 2.3 mA in both series.
Relatively high thresholds were obtained in our 1st case,
but they were mostly stable. Thus, the thresholds during
long-term follow-up periods were acceptable and lead
dislodgement was not observed in either cases.
Recently, the indication of biatrial pacing is
emphasized for the prevention of refractory atrial
tachyarrhythmias. 4 In such cases, CS pacing is a
necessary site for left atrial pacing. Therefore, the longterm prognosis of CS leads is major concern. Rosenthal
and Cook reported that significant adhesions to the
coronary veins were found 12 years after placing a
pacing lead in the posterolateral coronary vein.5 The
results of their observation and the presented cases
support that the long-term CS pacing is feasible with
safety. It may encourage selecting the CS as a site for
multisite pacing if it is needed.

References
1. Greenberg P, Castellanet M, Messenger J, et al. Coronary sinus
pacing clinical follow-up. Circulation 1978;57:98-103.
2. Moss AJ, Rivers RJ Jr. Atrial pacing from the coronary vein.
Ten-year experience in 50 patients with implanted pervenous
pacemakers. Circulation 1978;57:103-6.
3. Napodano RJ, Cannon E, Zaroff L. Two observations regarding
pervenous atrial pacing from the coronary sinus. J Electrocardiol
1971;4:275-8.
4. Daubert C, Gras D, Berder V, et al. Permanent atrial
resynchronization by synchronous bi-atrial pacing in the
preventive treatment of atrial flutter associated with high degree
interatrial block. Arch Mal Coeur Vaiss 1994;87(11 Suppl):
1535-46.
5. Rosenthal E, Cook A. Pacing lead adhesions after long-term
ventricular pacing via the coronary sinus. Pacing Clin
Electrophysiol 1999;22:1846-8.

January/April 2004

J HK Coll Cardiol, Vol 12

